Koen Van den Brande BREAKING
NEWS
Read more
Webinar - Session 3 - THE TECHNICAL VALIDATION STUDY PROTOCOL LATEST
VIDEO
More Videos
Frontiers Real-World Walking Speed Assessment Using
a Mass-Market RTK-GNSS Receiver
Luca Reggi, Luca Palmerini, Lorenzo Chiari, Sabato Mellone Other publications LATEST
PUBLICATION
SOCIAL MEDIA Mobilise-D Webinar – Up and Go: Planning & Conducting the Clinical Validation Study BREAKING
NEWS
Read more
Webinar - Session 3 - THE TECHNICAL VALIDATION STUDY PROTOCOL LATEST
VIDEO
More Videos
Frontiers Real-World Walking Speed Assessment Using
a Mass-Market RTK-GNSS Receiver
Luca Reggi, Luca Palmerini, Lorenzo Chiari, Sabato Mellone Other publications LATEST
PUBLICATION
SOCIAL MEDIA Webinar recordings available on our YouTube channel BREAKING
NEWS
Read more
Webinar - Session 3 - THE TECHNICAL VALIDATION STUDY PROTOCOL LATEST
VIDEO
More Videos
Frontiers Real-World Walking Speed Assessment Using
a Mass-Market RTK-GNSS Receiver
Luca Reggi, Luca Palmerini, Lorenzo Chiari, Sabato Mellone Other publications LATEST
PUBLICATION
SOCIAL MEDIA Mobilise-D links with Voice Global to promote global patient engagement BREAKING
NEWS
Read more
Webinar - Session 3 - THE TECHNICAL VALIDATION STUDY PROTOCOL LATEST
VIDEO
More Videos
Frontiers Real-World Walking Speed Assessment Using
a Mass-Market RTK-GNSS Receiver
Luca Reggi, Luca Palmerini, Lorenzo Chiari, Sabato Mellone Other publications LATEST
PUBLICATION
SOCIAL MEDIA Mobilise-D Patient and Public Information Pack BREAKING
NEWS
Read more
Webinar - Session 3 - THE TECHNICAL VALIDATION STUDY PROTOCOL LATEST
VIDEO
More Videos
Frontiers Real-World Walking Speed Assessment Using
a Mass-Market RTK-GNSS Receiver
Luca Reggi, Luca Palmerini, Lorenzo Chiari, Sabato Mellone Other publications LATEST
PUBLICATION
SOCIAL MEDIA Tom McQuillan BREAKING
NEWS
Read more
Webinar - Session 3 - THE TECHNICAL VALIDATION STUDY PROTOCOL LATEST
VIDEO
More Videos
Frontiers Real-World Walking Speed Assessment Using
a Mass-Market RTK-GNSS Receiver
Luca Reggi, Luca Palmerini, Lorenzo Chiari, Sabato Mellone Other publications LATEST
PUBLICATION
SOCIAL MEDIA

Connecting digital mobility assessment to clinical outcomes
for regulatory and clinical endorsement

What?

What?

Mobilise-D is a 5-year, IMI-funded project that will produce validated and accepted digital mobility outcomes to monitor daily life gait of people with different mobility problems, with the goal to improve follow-up and personalized care.

How?

How?

Mobilise-D will perform a technical and clinical validation of a sensor-algorithm pair in different patient groups. We maintain close dialogue with the European Medicines Agency (EMA) to facilitate the process of regulatory approval.

Who?

Who?

The Mobilise-D consortium consists of 34 partners from Europe and the USA. Over 200 professionals with technical, clinical, and regulatory expertise will work together to bring digital mobility outcomes to the clinic.                                                                  

Mobility – how well we walk – is an important marker of health; a slow walking speed is associated with greater mortality, morbidity, cognitive decline, dementia, and fall risk. As the population ages, the number of people experiencing mobility challenges is expected to rise. However, accurately assessing people’s mobility, especially in the real daily life world, is far from easy.

Mobilise-D will develop a comprehensive system to monitor and evaluate people’s gait based on digital technologies, including sensors worn on the body. The project focuses on conditions which often affect mobility, namely chronic obstructive pulmonary disease, Parkinson’s disease, multiple sclerosis, hip fracture recovery, and congestive heart failure.

The Mobilise-D results will help to improve the accurate assessment of daily life mobility in clinical trials and patient treatment, thereby contributing to improved and more personalised care.

Patient Groups

Mobilise-D will focus on five different patient groups that together represent respiratory problems (chronic obstructive pulmonary disease – COPD), neurodegenerative conditions (Parkinson’s disease – PD), neuroinflammatory problems (multiple sclerosis – MS), osteoporosis and sarcopenia (hip fracture recovery/proximal femoral fracture – PFF), and cardiac pathology (congestive heart failure – CHF).

These patient groups cover a range of walking speed, mobility challenges, and potential events that we care about, such as improving versus worsening of function, falls, hospitalisation, nursing home admission, and death. Furthermore, these patient groups will be followed at 12 different sites across Europe, ensuring a good geographical representation and covering a diverse representation of health care organisation, such as in- versus outpatient care, as well as public versus private health services.

Read More

Twitter Feed


📢PPIE Webinar on June 1📢

Only ONE week until our webinar "Putting patients in the centre when developing Digital Mobility Outcomes". Here is a teaser for you🤩👇

Register NOW!
https://t.co/UeNbQZlhOe

#PPIE #PatientVoice #DMOs #PD #MS #COPD #PFF @IHIEurope @EFPIA @AliKeogh88 https://t.co/AL3WkX3fro

📢Webinar Session 6 available on YouTube📢

📺You can now watch our webinar Session 6 "Up and Go: Planning and conducting the clinical validation study" on our YouTube channel:

🔗 https://t.co/3DMLFWoi3R

Previous webinars:
https://t.co/Tj9UdclMrF

#MobiliseD @IHIEurope @EFPIA

Latest News

“The End” of Work Package 2 – Algorithm development and technical validation

The work on algorithm development and technical validation has come to an end. We cannot believe it’s been three years already!  The Mobilise-D webinar series on the Technical Validation Study (TVS) had its fifth and last session on April 9, 2022. In this session, we showed how the sum of every single contribution in WP2…